D. E. Shaw & Co., Inc. Axonics, Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $28,047 - $36,210	-568 Reduced 14.59%	3,325 $206,000
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $1.78 Million - $2.29 Million	-36,598 Reduced 90.39%	3,893 $218,000
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $7.69 Million - $9.64 Million	-160,148 Reduced 79.82%	40,491 $2.04 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $882,628 - $1.13 Million	16,780 Added 9.13%	200,639 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $5.17 Million - $6.65 Million	86,788 Added 89.41%	183,859 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $5.63 Million - $7.58 Million	97,071 New	97,071 $6.84 Million
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $1.73 Million - $2.54 Million	-34,627 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $2.05 Million - $2.72 Million	34,627 New	34,627 $2.25 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.